InterVenn Biosciences utilizes a proprietary high-throughput glycoproteomic interrogation platform using artificial intelligence and mass spectrometry for next-gen precision medicine. The company is working to find new solutions in ovarian, pancreatic, liver, prostate, and kidney cancer, together with applications from the Vista suite of solutions for treatment and monitoring, immune profiling, patient stratification, and disease progression.

Biotechnology

InterVenn Biosciences

Joshua Stahl

Navya Ghanta

Noy Novera

Peter S.

Andrew Quong

Kim MacMartin-Moglia

Daan Hommes

Fadzhari Jabar

Ada Wong

Axel Kornerup

Xin Cong

Kaitlynn Moser

Dan Serie

The leadership team at InterVenn Biosciences has a history of experience in entrepreneurship, business administration, computer science, law, and biochemistry. They have also worked in a variety of industries, including quality assurance, operations, and security.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at InterVenn Biosciences

Board of Directors

CEO and Executive Team